|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade de Coimbra, 3004-535 Coimbra, Portugal
2 Centro de Neurociências de Coimbra, Universidade de Coimbra, 3004-517 Coimbra, Portugal
Reprint requests to: Rui M.M. Brito, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade de Coimbra, 3004-535 Coimbra, Portugal; e-mail: brito{at}ci.uc.pt; fax: +351-239-827703.
(RECEIVED August 17, 2005; FINAL REVISION October 6, 2005; ACCEPTED October 12, 2005)
| Abstract |
|---|
|
|
|---|
-sheets with the
-strands perpendicular to the main axis of the protofilament and a helical twist with a period of ~48
-strands. This TTR proto-filament model may be an important step in the understanding of the molecular mechanisms of TTR aggregation, as well as, a valuable instrument in drug design strategies against amyloid diseases. Keywords: Transthyretin; amyloid; protofilament; protein docking; supramolecular assembly
Abbreviations: EPR, electron paramagnetic resonance NearNI, near-native interface NonNI, non-native interface TTR, Transthyretin
Article published online ahead of print. Article and publication date are at http://www.proteinscience.org/cgi/doi/10.1110/ps.051787106.
Transthyretin (TTR) is one of several proteins known to be involved in human amyloid diseases. TTR is a homotetrameric protein mostly found in the plasma and the cerebral spinal fluid, and has been identified as the causative agent of such diseases as Familial Amyloidotic Polyneuropathy, Familial Amyloidotic Cardiomyopathy, and Senile Systemic Amyloidosis. It is believed that, in the process of amyloid formation, TTR dissociates to non-native monomeric units, which may act as the building blocks of the amyloid fibrils (Lai et al. 1996; Quintas et al. 1999, 2001; for review, see Brito et al. 2003). The structural characterization of these fibrils and the identification of the entities involved in fibril assembly are crucial for understanding of the mechanisms of pathogenesis in amyloid diseases, and for the development of appropriate therapeutic strategies. Experimental techniques have not yet been able to produce a high-resolution structure of an amyloid fibril of TTR. The work presented here proposes a high-resolution working model of the elementary units that constitute the fibrils, the protofilaments.
Each TTR subunit has a
-sandwich fold composed of two four-stranded
-sheets labeled DAGH and CBEF, as shown in Figure 1
. In the native protein, the
-sheets from two monomers associate edge-to-edge through
-strands H/H' and F/F' to produce a dimer composed of two extended
-sheets formed by strands DAGHH'G'A'D' and CBEFF'E'B'C'. Association of two of these dimers mainly through hydrophobic interactions mediated by the AB and GH loops forms the functional homotetramer.
|
-strands F and F' maintained, and a new intersubunit interface formed between
-strands B and B', in order to build the continuous extended cross-
structure characteristic of amyloid. The formation of this new interface implies the displacement of strands C and D from the
-sandwich. Additionally, Olofsson et al. (2004) identified a core region of the TTR subunit with large solvent protection factors. The data indicate that strands B, E, and F and strands G and H of the TTR subunit are, if not totally, partially maintained in the fibrils. The presence of solvent-exposed residues in strands C and D, as well as in the connecting and the following loops, clearly shows that this region is not part of the fibrillar core. Taken together, these results support a protofilament structure formed by a core of two three-stranded
-sheets (BEF and AGH) (Fig. 1
To build a molecular model in accordance with the structural characteristics mentioned above, two sets of docking computations were performed using the program HADDOCK (Dominguez et al. 2003): one set to recreate the near-native interface (NearNI) and another set to build the new non-native interface (NonNI) (Table 1
). The docking procedure is driven by a combination of shape complementarity and energetic criteria, and uses ambiguous interaction restraints, defined between any atom of the active residues of the ligand protein and all atoms of all active and passive residues of the receptor protein. Active residues are those residues experimentally identified to be involved in the interaction and solvent-accessible in the monomeric form of the protein. Passive residues are all solvent-accessible neighbors of active residues. Active and passive residues were defined based on NMR H/D exchange data (Olofsson et al. 2004) and solvent-accessibility calculations (Table 1
). Additional restraints for the NearNI and NonNI interfaces were defined according to distances experimentally determined by EPR (Serag et al. 2001, 2003; Table 1
). To generate the NearNI, two native monomers were docked against each other at their native interface (F/F' and H/H'), generating near-native dimeric structures. To generate the NonNI, two partially disrupted monomers (Fig. 1
) were created by deleting
-strands C and D and loops AB and CD. These partially disrupted monomers were then docked at the A/A'B/B' interface, generating non-native dimeric structures. Two thousand docked structures were calculated for each docking run, and the best dimeric structures, with the lowest intermolecular energies and obeying all experimental constraints, were kept.
|
-sheets. These structures have helical periods in the range of 710 dimers, showing that subtle structural differences in the interfaces are of paramount importance for overall supramolecular geometry. A detailed analysis of the differences among protofilament structural families will be presented elsewhere.
|
-strands perpendicular to the main protofilament axis, which is generally accepted as a characteristic of amyloid, the so-called cross-
structure (Eanes and Glenner 1968). In order to rebuild the full polypeptide chain in each TTR subunit, the peptide fragments initially removed to create the partially disrupted monomers were added. These peptide sequences, comprising
-strands C and D and loops AB and CD, were energy-minimized and subjected to a short molecular dynamics run, without interfering with the subunit interfaces or the subunit core. The final protofilament structure obtained is formed by two extended continuous
-sheets, (BEFF'E'B')n and (AGHH'G'A')n, with the
-strands nearly perpendicular to the main axis of the protofilament. The protofilament, with a diameter of ~50 Å, presents a helical twist with a period of ~48
-strands, that is, 16 monomeric units with two three-stranded
-sheets each (BEF and AGH) (Fig. 3
|
It is interesting to note that, based on X-ray fiber diffraction studies, Blake and Serpell (1996) proposed a model for TTR amyloid consisting of extended
-sheets with a helical twist and a fiber repeating unit of ~115 Å, corresponding to 24
-strands. It must be more than coincidental that our model, based on energetic and shape complementarity criteria, has a helical period double than Blakes model. In fact, it is possible that the X-ray diffraction pattern observed for the fiber could be the result of lateral association of protofilaments shifted by half-period. If this is not the case, to build a protofilament with a period of 24
-strands a much more twisted helical structure is required, and a large conformational rearrangement of the
-sheets in the TTR subunit is necessary. Interestingly, our protofilament model shows surface segregation of charged residues in a helical arrangement, which could be responsible for the half-period pairing of protofilaments, in order to avoid electrostatic repulsions.
In summary, our results show that docking two TTR subunits to recreate a non-native interface involving
-strands A and B requires full solvent exposure of these strands. The docking and alignment procedure generated a range of protofilament structures, in agreement with the structural polymorphism observed for amyloid fibrils and recently reported (Cardoso et al. 2002; Jansen et al. 2005). The protofilament structure proposed here has geometric properties in close agreement with the known characteristics of TTR amyloid. Several experimental studies have shown that TTR amyloid fibrils are formed by continuous
-sheet helices (Blake and Serpell 1996) and protofilaments with diameters in the order of 4060 Å, as revealed by electron microscopy and X-ray fiber diffraction (Serpell et al. 1995; Sunde et al. 1997). Additionally, all the EPR distance restraints and NMR protection factors initially imposed are observed in the final structures, and the generated structures have good stereochemical properties. This model may be refined in the future by the introduction of other experimentally derived constraints, but at this stage may become a valuable instrument in the rational design of compounds with therapeutic potential to inhibit amyloid fibril formation by TTR.
| Footnotes |
|---|
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
Blake, C. and Serpell, L. 1996. Synchroton X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous
-sheet helix. Structure 4: 989998.[Medline]
Brito, R.M.M., Damas, A.M., and Saraiva, M.J. 2003. Amyloid formation by Transthyretin: From protein stability to protein aggregation. Curr. Med. Chem. Immun. Endoc. Metab. Agents 3: 349360.
Cardoso, I., Goldsbury, C.S., Müller, S.A., Olivieri, V., Wirtz, S., Damas, A.M., Aebi, U., and Saraiva, M.J. 2002. Transthyretin fibrillogenesis entails the assembly of monomers: A molecular model for in vitro assembled Transthyretin amyloid-like fibrils. J. Mol. Biol. 317: 683695.[CrossRef][Medline]
Daura, X., Gademann, K., Jaun, B., Seebach, D., van Gunsteren, W.F., and Mark, A.E. 1999. Peptide folding: When simulation meets experiment. Angew. Chem. Int. Ed. 38: 236240.[CrossRef]
Dominguez, C., Boelens, R., and Bonvin, A.M.J.J. 2003. HADDOCK: A proteinprotein docking approach based on biochemical or biophysical information. J. Am. Chem. Soc. 125: 17311737.[CrossRef][Medline]
Eanes, E.D. and Glenner, G.G. 1968. X-ray diffraction studies on amyloid filaments. J. Histochem. Cytochem. 16: 673677.[Abstract]
Hornberg, A., Eneqvist, T., Olofsson, A, Lundgren, E., and Sauer-Eriksson, A.E. 2000. A comparative analysis of 23 structures of the amyloidogenic protein Transthyretin. J. Mol. Biol. 302: 649669.[CrossRef][Medline]
Humphrey, W., Dalke, A., and Schulten, K. 1996. VMDVisual Molecular Dynamics. J. Mol. Graph. 14: 3338.[CrossRef][Medline]
Jansen, R., Dzwolak, W., and Winter, R. 2005. Amyloidogenic self-assembly of insulin aggregates probed by high resolution atomic force microscopy. Biophys. J. 88: 13441353.
Kale, L., Skeel, R., Bhandarkar, M., Brunner, R., Gursoy, A., Krawetz, N., Phillips, J., Shinozaki, A., Varadarajan, K., and Shulten, K. 1999. NAMD2: Greater scalability for parallel molecular dynamics. J. Comp. Phys. 151: 283312.[CrossRef]
Lai, Z., Colon, W., and Kelly, J.W. 1996. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry 35: 64706482.[CrossRef][Medline]
Laskowski, R.A., MacArthur, M.W., Moss, D.S., and Thornton, J.M. 1993. PROCHECK: A program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26: 283291.[CrossRef]
Lindahl, E., Hess, B., and van der Spoel, D. 2001. Gromacs 3.0: A package for molecular simulation and trajectory analysis. J. Mol. Mod. 7: 306317.
Olofsson, A., Ippel, J.H., Wijmenga, S.S., Lundgren, E., and Öhman, A. 2004. Probing solvent accessibility of transthyretin amyloid by solution NMR spectroscopy. J. Biol. Chem. 279: 56995707.
Quintas, A., Saraiva, M.J., and Brito, R.M.M. 1999. The tetrameric protein transthyretin dissociates to a non-native monomer in solution. A novel model for amyloidogenesis. J. Biol. Chem. 274: 3294332949.
Quintas, A., Vaz, D.C., Cardoso, I., Saraiva, M.J., and Brito, R.M.M. 2001. Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants. J. Biol. Chem. 276: 2720727213.
Serag, A.A., Altenbach, C., Gingery, M., Hubbell, W.L., and Yeates, T.O. 2001. Identification of a subunit interface in transthyretin amyloid fibrils: Evidence for self-assembly from oligomeric building blocks. Biochemistry 40: 90899096.[CrossRef][Medline]
. 2003. Arrangement of subunits and ordering of
-strands in an amyloid sheet. Nat. Struct. Biol. 9: 734739.
Serpell, L.C., Sunde, M., Fraser, P.E., Luther, P.K., Morris, E.P., Sangren, O., Lundgren, E., and Blake, C.C.F. 1995. Examination of the structure of the Transthyretin amyloid fibril by image reconstruction from electron micrographs. J. Mol. Biol. 254: 113118.[CrossRef][Medline]
Sunde, M., Serpell, L.C., Bartlam, M., Fraser, P.E., Pepys, M.B., and Blake, C.C.F. 1997. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 273: 729739.[CrossRef][Medline]
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |